NCT04287478View on ClinicalTrials.gov

Bacteriophage Therapy in Patients With Urinary Tract Infections

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

December 9, 2020

Primary Completion Date

February 28, 2023

Study Completion Date

February 28, 2023

Conditions
Urinary Tract Infection Bacterial
Interventions
BIOLOGICAL

Bacteriophage Therapy

Bacteriophage therapy will be personalized for each patient dependent on phage susceptibility testing

Trial Locations (8)

10468

James J. Peters VA Medical Center, The Bronx

33157

Innovation Medical Research Center, Inc, Palmetto Bay

33166

Universal Axon Clinical Research, Doral

33169

AMPM Research Clinic, Miami Gardens

33176

AdMed Research, Miami

48202

Henry Ford Hospital, Detroit

75390

University of Texas Southwestern Medical Center, Dallas

78539

DHR Health Institute for Research and Development, Edinburg

Sponsors
All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Adaptive Phage Therapeutics, Inc.

INDUSTRY

NCT04287478 - Bacteriophage Therapy in Patients With Urinary Tract Infections | Biotech Hunter | Biotech Hunter